NFκB pathway is down-regulated by 1α,25(OH)2-vitamin D3 in endothelial cells transformed by Kaposi sarcoma-associated herpes virus G protein coupled receptor

Steroids

Volumn 77, Issue 11, 2012, Pages 1025-1032

  Gonzalez Pardo, Verónica ^a,b   D'Elia, Noelia ^a   Verstuyf, Annemieke ^b   Boland, Ricardo ^a   Russo De Boland, Ana ^a  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

1 ,25(OH)2D3; Kaposi sarcoma; NF B pathway; VDR

Indexed keywords

BORTEZOMIB; CALCITRIOL; COLECALCIFEROL RECEPTOR; G PROTEIN COUPLED RECEPTOR; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN KINASE B;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; DOWN REGULATION; ENDOTHELIUM CELL; HERPES VIRUS; HUMAN; HUMAN CELL; KAPOSI SARCOMA; PROTEIN SYNTHESIS;

ANTINEOPLASTIC AGENTS; BORONIC ACIDS; CALCITRIOL; CELL LINE, TRANSFORMED; CELL PROLIFERATION; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HERPESVIRUS 8, HUMAN; HUMANS; I-KAPPA B PROTEINS; NF-KAPPA B; PROTEIN TRANSPORT; PYRAZINES; RECEPTORS, CALCITRIOL; RECEPTORS, CHEMOKINE; RECEPTORS, VIRUS; SIGNAL TRANSDUCTION;

HERPESVIRIDAE;

EID: 84865496680     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2012.05.006     Document Type: Article

References (36)

1. 3 receptor agonist Blood 96 2000 3188 3194
2. D. Martin, R. Galisteo, Y. Ji, S. Montaner, and J.S. Gutkind An NFκB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia Oncogene 27 2008 1844 1852
3. M.S. Hayden, and S. Ghosh Signaling to NF-kappaB Genes Dev 18 2004 2195 2224
4. G. Bonizzi, and M. Karin The two NF-kappaB activation pathways and their role in innate and adaptive immunity Trends Immunol 25 2004 280 288
5. C. Nakanishi, and M. Toi Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs Nat Rev Cancer 5 2005 297 309
6. P. Viatour, M.P. Merville, V. Bours, and A. Chariot Phosphorylation of NF-kB and IkB proteins: implications in cancer and inflammation Trends Biochem Sci 30 2005 43 52
7. H. DeLuca Evolution of our understanding of vitamin D Nutr Rev 10 2008 S73 S87
8. F. Baeke, T. Takiishi, H. Korf, C. Gysemans, and C. Mathieu Vitamin D: modulator of the immune system Curr Opin Pharmacol 10 2010 482 496
9. T.M. Beer, and A. Myrthue Calcitriol in cancer treatment: from the lab to the clinic Mol Cancer Ther 3 2004 373 381
10. M.R. Haussler, G.K. Whitfield, C.A. Haussler, J.C. Hsieh, P.D. Thompson, and S.H. Selznick The nuclear vitamin D receptor: biological and molecular regulatory properties revealed J Bone Miner Res 13 1998 325 349
11. J. Yanagisawa, Y. Yanagi, Y. Masuhiro, M. Suzawa, M. Watanabe, and K. Kashiwagi Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators Science 283 1993 1317 1321
12. 3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling J Cell Biol 154 2001 369 387
13. 3-stimulated transcription J Cell Biochem 92 2004 833 848
14. Y. Jian, J. Yan, H. Wang, C. Chen, M. Sun, and J. Jiang Cyclin D3 interacts with vitamin D receptor and regulates its transcription activity Biochem Biophys Res Commun 335 2005 739 748
15. 3 regulates NF-kappaB DNA binding activity in cultured normal human keratinocytes through an increase in IkappaBalpha expression Arch Dermatol Res 296 2004 195 202
16. 3 induces biphasic NF-κB responses during HL-60 leukemia cells differentiation through protein induction and PI3K/Akt-dependent phosphorylation/degradation of IκB Exp Cell Res 313 2007 1722 1734
17. 3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells Mol Immunol 47 2010 1728 1738
18. 3 decreases DNA binding of nuclear factor-kappaB in human fibroblasts FEBS Lett 436 1998 329 334
19. J. Sun, J. Kong, Y. Duan, F.L. Szeto, A. Liao, and J.L. Madara Increased NF- B activity in fibroblasts lacking the vitamin D receptor Am J Physiol Endocrinol Metab 291 2006 315 322
20. M. Cohen-Lahav, S. Shany, D. Tobvin, C. Chaimovitz, and A. Douvdevan Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels Nephrol Dial Transplant 21 2006 889 897
21. 3 and its TX527 analog inhibit the growth of endothelial cells transformed by Kaposi sarcoma-associated herpes virus G protein-coupled receptor in vitro and in vivo Endocrinology 151 2010 23 31
22. S. Montaner, A. Sodhi, A. Molinolo, T.H. Bugge, E.T. Sawai, and Y. He Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes Cancer Cell 3 2003 23 26
23. 3 stimulates intestinal cell p38 MAPK activity and increases c-fos expression Int J Biochem Cell Biol 38 2006 1181 1190
24. V. González Pardo, R. Boland, and A. Russo de Boland Ageing alters vitamin D receptor levels and binding properties in rat subcellular fractions Biogerontology 9 2008 109 118
25. 2-vitamin D3: activation of muscle PLCγ through the tyrosine kinase c-Src and Ptdlns-3kinase Eur J Biochem 269 2002 2506 2515
26. C. Blackburn, K.M. Gigstad, P. Hales, K. Garcia, M. Jones, and F. Bruzzese Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β 5-subunit Biochem J 430 2010 461 476
27. D. Martin, and J.S. Gutkind Human tumor-associated viruses and new insights into the molecular mechanisms of cancer Oncogene 2 2008 S31 S42
28. 3:implications in cell growth and differentiation Endocr Rev 23 2002 763 786
29. M. Nishikori Classical and alternative NF-kB activation pathways and their roles in lymphoid malignancies J Clin Exp Hematopathol 45 2005 15 24
30. J.T. Wu, and J.G. Kral The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy J Surg Res 123 2005 158 169
31. 3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene J Clin Invest 101 1998 252 262
32. 3 and its analogs: physiologic and therapeutic implications for dendritic cell function J Biol Chem 278 2003 49378 49385
33. 3 Proc Natl Acad Sci USA 92 1995 10990 10994 [Erratum in: Proc Natl Acad Sci USA 93:Jan 1996, p. 524.]
34. N. Shembade, A. Ma, and E.W. Harhaj Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes Science 327 2010 1135 1139
35. N. Auphan, J.A. DiDonato, C. Rosette, A. Helmberg, and M. Karin Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis Science 270 1995 286 290
36. R.I. Scheinman, P.C. Cogswell, A.K. Lofquist, and A.S. Baldwin Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids Science 270 1995 283 286